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ABSTRACT 
Patients of valvular heart disease treated with mechanical valve replacement are required to be on lifelong medication with 
anticoagulants. Complications may arise when adequate International Normalized Ratio (INR) control is not maintained, 
leading to thromboembolic events, but very few cases have been reported where these complications arise despite therapeutic 
INR control. We, here, highlight a case of rare fatal complication of Acute Coronary Syndrome in a one month postoperative 
patient of Dual Mechanical Valve Replacement with therapeutic INR, which evaded correct diagnosis due to unawareness on 
the part of the treating team of physicians. 
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oung patients (<60years) with valvular heart 
diseases, having longer life expectancy, are 
preferentially treated with valve replacement 
using mechanical valves as these valves have longer 
durability and lower need of reoperation, but also require 
lifelong use of anticoagulant medications [1,2]. The 
recommended range of International Normalized Ratio 
(INR) for patients of double valve replacement (DVR) is 
2.0-3.0 [3], with the risk of embolism being lowest for 
INR range of 2.5-4.9 [4]. Patients maintaining a good 
compliance with their medication have a very low risk of 
embolism, estimated at 0.4-1.4% patient years [5]. We 
present an unusual complication of coronary 
thromboembolism, one month following mechanical valve 
replacement in a 34 year old male within therapeutic INR, 
which was diagnosed posthumously. We want to present 
this case due to the rarity of this fatal complication. 
 
CASE REPORT 
A 34 year old male patient presented to the emergency 
room with the complaints of shortness of breath and 
palpitations for a few hours duration, one month post-
operatively after undergoing a surgery for dual heart valve 
replacement due to rheumatic heart disease (RHD) with 
severe mitral Stenosis (MS) and moderate aortic 
regurgitation (AR). 
His vitals on re-admission were normal with SpO2 of 
98% on room air. He was diaphoretic and appeared in 
distress. His INR was 3.0 (Goal INR was 3-3.5). 
Electrocardiography showed ventricular tachyarrhythmia 
and ST-elevation with non-progression of R wave pattern, 
(Fig. 1A & 1B). Echocardiography showed global left 
ventricular hypokinesis with ejection fraction (EF) of 15%, 
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with both mechanical valves were functioning 
satisfactorily, and there was no evidence of pannus or 
thrombus on either valvular surface and no clots or 
collections in the pericardium. Coronary angiography was 
not performed as the patient had therapeutic range of INR 
ruling out the diagnosis of coronary thromboembolism. 
 
 
Figure 1A & 1B - ECG of the patient on the day of re-
admission to the emergency room, showing ST segment 
elevation with Ventricular Tachyarrhythmia pattern. 
Subsequently, the patient developed runs of 
ventricular fibrillation (VF), requiring defibrillation and 
Amiodarone loading with maintenance infusion. When the 
patient continued to have VF, he was started on Xylocard 
2% infusion which led to cessation of the arrhythmia. His 
symptoms were thought to originate from left ventricular 
dysfunction, and ECG findings presumed to arise from 
pericardial changes. He died 48 hours after admission, due 
to intractable VF, despite all resuscitative measures and 
without an assertive diagnosis of his presentation. 
His previous hospital stay during the valve 
replacement surgery had been uneventful, and his 
evaluation had shown no predisposing risk factors for 
thromboembolism. His pre-operative echocardiography 
had shown EF of 30%, anterior mitral leaflet was  
thickened and calcified, and posterior mitral leaflet was 
calcified and fixed, causing severe MS. Aortic valve (AV) 
cusps were thickened and retracted causing moderate AR, 
and severe left ventricular (LV) systolic dysfunction with 
dilated LV dimensions of LVID(ed) = 6.3cm and 
LVID(es) = 5.8cm. He had undergone DVR surgery, 
during which his mitral valve (MV) was replaced using 
ON-X (25/33) conform mechanical valve, (internal orifice 
- 4.1 cm
2
), preserving the subvalvular apparatus and AV 
was replaced with 21mm conform ON-X valve, (internal 
orifice - 2.84cm
2
). His post-operative echocardiography 
had shown normally functioning mitral and aortic 
mechanical prosthesis with mean and peak gradients of 4 
and 8 in mitral position, and 8 and 14 in aortic position, 
respectively. He had been discharged on 5
th
 post operative 
day with an uneventful postoperative recovery, till he 
presented again to the emergency department one month 
later. His medications on discharge had included 
Metoprolol, Torsemide daily, Perindopril and 
Acenocumerol (equivalent of warfarin) in adequate doses 
and compliance was also good. 
The post mortem examination showed evidence of 
coronary thromboembolism involving the left anterior 
descending (LAD) artery, prompting the treating 
physicians to the posthumous diagnosis of acute coronary 
syndrome (ACS), most likely arising from micro-thrombus 
on the mechanical valves, which he must have developed 
despite being on oral anticoagulation medication with 
good compliance and maintaining his goal INR. 
DISCUSSION 
Thromboembolic complications are not common events in 
patients with a good anticoagulant control and therapeutic 
INR. This was a young patient, who presented in his early 
post operative period, with thromboembolic complications 
in the coronary artery, which evaded correct diagnosis due 
to INR values being in the recommended range, and he, 
also, did not have any risk factors or a positive family 
history for ischemic heart disease or thromboembolism. 
Echocardiographic findings on neither of occasions 
suggested the presence of thrombus or pannus 
development on the mechanical valvular surfaces. In our 
extensive search of the published literature, we have not 
found a similar case presentation in so young patients, 
having good anticoagulant control and presenting in early 
post operative period. 
A recent trial by Puskas et al has suggested that use of 
ON-X mechanical valves for AV replacement may be 
managed with lower doses of anticoagulant medication 
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which eventually results in significant lower risk of 
bleeding without affecting the risk of thromboembolism 
[6]. In a case series reported by Iakobishvili et al, found 
that the median time from implantation of a prosthetic 
valve to the development of the ACS was 8 years and that 
majority of such patients had 2 or more risk factors 
associated with atherosclerosis [7]. 
Wongrakpanich et al reported a case of coronary 
thromboembolism in a 54 year old male patient with dual 
prosthetic heart valves who was operated upon 20 years 
ago, and the patient received successful management by 
coronary angiography and thrombectomy with an 
eliminate aspiration catheter [8]. In a similar case reported 
by Sharma et al, a 35 year old female with DVR surgery, 
done 10 years prior and no coronary risk factors developed 
ACS. She had discontinued her oral anticoagulation 
medication three months earlier, but was successfully 
managed with balloon angioplasty [9]. 
Fernandez et al reported a case series of 4 patients 
who had developed massive thrombosis of Aortic Bjork-
Shiley prosthesis despite a well maintained anticoagulation 
therapy [10]. Karakoyun et al reported a series of non-ST 
elevation ACS in three patients with single prosthetic 
valve replacement surgery done 5, 3, and 6 years after 
valve replacement, respectively [11]. All of them were 
successfully managed with thrombolytic therapy using low 
dose tissue plasminogen activator (t-PA). Levis et al 
reported a case of myocardial infarction in a 50 year old 
patient with tissue AV replacement done four years ago 
due to coronary artery embolism [12]. He was managed 
with percutaneous transluminal coronary angioplasty with 
balloon angioplasty and aspiration thrombectomy. 
Conclusion 
This case highlights the importance of entertaining a 
diagnosis of ACS in patient with suggestive findings, 
despite good anticoagulant control and therapeutic INR 
and ruling this out by timely and adequate cardiac 
imaging.  
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